Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.180
-0.060 (-1.85%)
Jan 29, 2026, 2:21 PM EST - Market open
Aquestive Therapeutics Employees
Aquestive Therapeutics had 142 employees as of December 31, 2024. The number of employees increased by 7 or 5.19% compared to the previous year.
Employees
142
Change (1Y)
7
Growth (1Y)
5.19%
Revenue / Employee
$305,613
Profits / Employee
-$485,768
Market Cap
387.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 142 | 7 | 5.19% |
| Dec 31, 2023 | 135 | 5 | 3.85% |
| Dec 31, 2022 | 130 | -27 | -17.20% |
| Dec 31, 2021 | 157 | -30 | -16.04% |
| Dec 31, 2020 | 187 | -45 | -19.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 869 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Evolus | 329 |
| Akebia Therapeutics | 181 |
| SIGA Technologies | 46 |
AQST News
- 2 days ago - SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - Newsfile Corp
- 6 days ago - AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - GlobeNewsWire
- 16 days ago - Aquestive Therapeutics Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through the Firm's Investigation - Newsfile Corp
- 16 days ago - Aquestive Therapeutics: Anaphylm Will Probably Survive This Regulatory Hurdle - Seeking Alpha
- 16 days ago - INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - Newsfile Corp
- 20 days ago - Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application - Benzinga
- 20 days ago - BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover Losses - GlobeNewsWire
- 20 days ago - Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update - GlobeNewsWire